Mesenchymal stromal cells (MSCs), present in the stromal component of several tissues,
include multipotent stem cells, progenitors, and differentiated cells. MSCs have quickly …

Peripheral artery disease (PAD) poses a great challenge to society, with a growing
prevalence in the upcoming years. Patients in the severe stages of PAD are prone to …

Critical limb ischemia (CLI), the terminal stage of peripheral arterial disease (PAD), is
characterized by an extremely high risk of amputation and vascular issues, resulting in …

Progressive peripheral arterial disease (PAD) can result in chronic limb-threatening
ischemia (CLTI) characterized by clinical complications including rest pain, gangrene and …

Introduction Critical limb ischemia (CLI) is the most advanced form of peripheral arterial
disease (PAD) characterized by ischemic rest pain and non-healing ulcers. Currently, the …

Rhodiola is an ancient wild plant that grows in rock areas in high-altitude mountains with a
widespread habitat in Asia, Europe, and America. From empirical belief to research studies …

Abstract Background Mesenchymal stromal cells (MSCs), commonly sourced from adipose
tissue, bone marrow and umbilical cord, have been widely used in many medical conditions …

Advanced therapy medicinal products (ATMPs) offer new prospects to improve the treatment
of conditions with unmet medical needs. Kidney diseases are a current major health concern …

Producing human mesenchymal stromal cells (MSCs) for clinical use requires adherence to
current good manufacturing practice (cGMP) standards. This is necessary for ensuring …

Abstract Mesenchymal Stem Cells (MSCs) are non‐hematopoietic and multipotent stem
cells, which have been considered in regenerative medicine. These cells are easily …